Barely Significant
← all excerpts

Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGF<i>B</i> signalling in vitro and in an OIM mouse model.

Bone Rep · 2024 · PMC11344016 · PMID 39185375

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

a strong trendP = 0.07so close (0.05 < p ≤ 0.1)
No significant alterations in cortical bone volume were observed, although there was a strong trend towards increased cortical bone volume following administration of 0.6 g/L losartan ( P = 0.07) and a significant increase in cortical thickness ( P < 0.001) ( Fig. 2 G–H).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.